AJANTPHARM.BOAJANTPHARM.BOBSE
Loading
Year-over-year operating income growth rate
Percentile
P44
Within normal range
vs 2Y Ago
0.3x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 3.97% |
| Q3 2025 | -52.27% |
| Q2 2025 | 25.43% |
| Q1 2025 | 91.04% |
| Q4 2024 | -54.76% |
| Q3 2024 | 25.26% |
| Q2 2024 | 105.95% |
| Q1 2024 | -15.07% |
| Q4 2023 | 11.85% |
| Q3 2023 | 3.55% |
| Q2 2023 | 61.99% |
| Q1 2023 | -10.52% |
| Q4 2022 | -16.08% |
| Q3 2022 | 7.37% |
| Q2 2022 | 5.90% |
| Q1 2022 | -13.69% |
| Q4 2021 | -10.13% |
| Q3 2021 | 22.16% |
| Q2 2021 | -20.64% |
| Q1 2021 | 12.25% |
| Q4 2020 | -13.57% |
| Q3 2020 | 25.98% |
| Q2 2020 | 31.75% |
| Q1 2020 | -8.75% |
| Q4 2019 | 5.13% |
| Q3 2019 | 6.07% |
| Q2 2019 | 24.40% |
| Q1 2019 | 32.04% |
| Q4 2018 | -40.40% |
| Q3 2018 | 5.99% |
| Q2 2018 | 14.18% |
| Q1 2018 | -32.67% |
| Q4 2017 | 7.89% |
| Q3 2017 | 48.35% |
| Q2 2017 | -19.96% |
| Q1 2017 | -12.42% |
| Q4 2016 | -3.78% |
| Q3 2016 | 10.09% |
| Q2 2016 | 17.83% |
| Q1 2016 | -14.31% |